Molecule intelOpportunity: Lower0

Ciclopirox Olamine

16 brands · 10 companies · product forms

Opportunity snapshot

Launch attractiveness
15
Market saturation
26
Price room
2
Regulatory risk
0
16
brands
10
companies
Rs 304.12
median price
3
price points
1.07x
price spread
90
confidence %

Who competes here

Top companies by brand count · leader share 25%

Price room

Across observed sources and strengths
CheapestRs 285.07
MedianRs 304.12
Most expensiveRs 304.12
Spread1.07×
Sources: DRAP-official, DVAGO

max/min price ratio 1.07x across 3 trusted points (Rs 285.07-304.12). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 1 live product for Ciclopirox Olamine — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(2) + 20% low-competition(74) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

10 canonical companies and 16 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 1.07x across 3 trusted points (Rs 285.07-304.12). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: no ATC code.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.